Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
ASM Case Reports|November 17, 2025
Bad to the bone: <i>Candida (Candidozyma) auris</i> vertebral osteomyelitis treated with combination antifungal therapy followed by a novel long-acting echinocandinLauryn B Jenkins, Robbie L Christian, Boris A Karaman, et al.
Microbiology Spectrum|March 31, 2026
Synergistic activity of dual β-lactams against <i>Mycobacterium avium</i> complexEunjeong Shin, Khalid M Dousa, Mary Nantongo, et al.
Open Forum Infectious Diseases|August 10, 2018
Ibrutinib Therapy and <i>Mycobacterium chelonae</i> Skin and Soft Tissue InfectionKhalid M Dousa, Ahmed Babiker, Daniel Van Aartsen, et al.
Idcases|April 29, 2020
SARS-CoV-2 infection in a patient on chronic hydroxychloroquine therapy: Implications for prophylaxisKhalid M Dousa, Sharad S Malavade, Jennifer Furin, et al.
Journal of Infection Prevention|April 13, 2023
Containment of COVID-19 outbreak at a veterans affairs community living centerKhalid M Dousa, Laura Hmiel, Brian Klonowski, et al.
Open Forum Infectious Diseases|January 12, 2019
Impact of Diabetes Mellitus on the Presentation and Response to Treatment of Adults With Pulmonary Tuberculosis in QatarKhalid M Dousa, Abdelrahman Hamad, Mohamed Albirair, et al.
ASM Case Reports|November 17, 2025
Successful treatment of macrolide-resistant <i>Mycobacterium abscessus</i> infection using multi-drug regimens including dual β-lactams and phage therapy: case reports in two childrenMasako Shimamura, Bradford Becken, Jessica Tansmore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 11, 2021
"One-Two Punch": Synergistic ß-Lactam Combinations for Mycobacterium abscessus and Target Redundancy in the Inhibition of Peptidoglycan Synthesis EnzymesDavid C Nguyen, Khalid M Dousa, Sebastian G Kurz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 30, 2025
The Role of β-Lactam Antibiotics in Treating Mycobacterium abscessus: From Laboratory Insights to Clinical Applications and the Case for Clinical TrialsKhalid M Dousa, Eunjeong Shin, Sebastian G Kurz, et al.
ACS Infectious Diseases|April 15, 2024
Durlobactam, a Diazabicyclooctane β-Lactamase Inhibitor, Inhibits BlaC and Peptidoglycan Transpeptidases of <i>Mycobacterium tuberculosis</i>Mary Nantongo, David C Nguyen, Christopher R Bethel, et al.
Pageof 3